Evaluation of the Drug Combination Nitazoxanide, Azithromycin, and Rifabutin as a Treatment for Cryptosporidium serpentis Infection in Eastern Indigo Snakes (Drymarchon couperi)

J. Bogan, Michelle Hoffman, M. Mitchell, M. Garner, A. Childress, J. Wellehan
{"title":"Evaluation of the Drug Combination Nitazoxanide, Azithromycin, and Rifabutin as a Treatment for Cryptosporidium serpentis Infection in Eastern Indigo Snakes (Drymarchon couperi)","authors":"J. Bogan, Michelle Hoffman, M. Mitchell, M. Garner, A. Childress, J. Wellehan","doi":"10.5818/JHMS-D-22-00014","DOIUrl":null,"url":null,"abstract":"Abstract Cryptosporidium serpentis is a common parasitic disease in captive snakes that is associated with substantial morbidity and mortality. To minimize the impact of this parasite, it is important to identify effective treatment methods. The purpose of this study was to evaluate a new drug regimen for treating C. serpentis in eastern indigo snakes (Drymarchon couperi). Twenty-four eastern indigo snakes naturally infected with C. serpentis were randomly divided into two groups. The first group received 20 mg/kg nitazoxanide, 10 mg/kg azithromycin, and 5 mg/kg rifabutin twice weekly in a food item for 6 wk, whereas the second group received no treatment in the food items. Cloacal swabs were collected every 2 months for 6 months to measure C. serpentis shedding by probe hybridization quantitative polymerase chain reaction (qPCR). The eastern indigo snakes that were qPCR negative after 6 months were immunosuppressed with a single dose of 4 mg/kg dexamethasone sodium phosphate SC. These eastern indigo snakes were then screened by qPCR for an additional 6 months as described previously. Eastern indigo snakes that were qPCR negative after 1 yr of serial sampling were re-evaluated for C. serpentis via gastric biopsy for histological and qPCR analyses. Only 2 (16.7%; 95% confidence interval [CI]: 0.1–37.8) of 12 eastern indigo snakes from each group were qPCR negative before immunosuppression. The eastern indigo snakes in the treatment group did have a decrease in the amount of C. serpentis DNA shedding after treatment (P = 0.025), whereas the control eastern indigo snakes did not (P = 0.232). Only 1 (8.3%; 95% CI: 0.1–23.9) of 12 eastern indigo snakes in each group was negative 6 months after immunosuppression. These findings suggest that 20 mg/kg nitazoxanide, 10 mg/kg azithromycin, and 5 mg/kg rifabutin twice weekly for 6 wk in a food item is ineffective in eliminating C. serpentis in naturally infected eastern indigo snakes.","PeriodicalId":16054,"journal":{"name":"Journal of Herpetological Medicine and Surgery","volume":"3 1","pages":"291 - 295"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Herpetological Medicine and Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5818/JHMS-D-22-00014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Abstract Cryptosporidium serpentis is a common parasitic disease in captive snakes that is associated with substantial morbidity and mortality. To minimize the impact of this parasite, it is important to identify effective treatment methods. The purpose of this study was to evaluate a new drug regimen for treating C. serpentis in eastern indigo snakes (Drymarchon couperi). Twenty-four eastern indigo snakes naturally infected with C. serpentis were randomly divided into two groups. The first group received 20 mg/kg nitazoxanide, 10 mg/kg azithromycin, and 5 mg/kg rifabutin twice weekly in a food item for 6 wk, whereas the second group received no treatment in the food items. Cloacal swabs were collected every 2 months for 6 months to measure C. serpentis shedding by probe hybridization quantitative polymerase chain reaction (qPCR). The eastern indigo snakes that were qPCR negative after 6 months were immunosuppressed with a single dose of 4 mg/kg dexamethasone sodium phosphate SC. These eastern indigo snakes were then screened by qPCR for an additional 6 months as described previously. Eastern indigo snakes that were qPCR negative after 1 yr of serial sampling were re-evaluated for C. serpentis via gastric biopsy for histological and qPCR analyses. Only 2 (16.7%; 95% confidence interval [CI]: 0.1–37.8) of 12 eastern indigo snakes from each group were qPCR negative before immunosuppression. The eastern indigo snakes in the treatment group did have a decrease in the amount of C. serpentis DNA shedding after treatment (P = 0.025), whereas the control eastern indigo snakes did not (P = 0.232). Only 1 (8.3%; 95% CI: 0.1–23.9) of 12 eastern indigo snakes in each group was negative 6 months after immunosuppression. These findings suggest that 20 mg/kg nitazoxanide, 10 mg/kg azithromycin, and 5 mg/kg rifabutin twice weekly for 6 wk in a food item is ineffective in eliminating C. serpentis in naturally infected eastern indigo snakes.
硝唑昔尼特、阿奇霉素、利福布汀联合治疗东部靛蓝蛇隐孢子虫感染的疗效评价
蛇隐孢子虫是圈养蛇中一种常见的寄生虫病,具有较高的发病率和死亡率。为了尽量减少这种寄生虫的影响,确定有效的治疗方法是很重要的。本研究的目的是评价一种治疗东部靛蓝蛇(Drymarchon couperi)蛇形弧菌的新药物方案。将24条自然感染蛇舌虫的东部靛蓝蛇随机分为两组。第一组每周两次在食物中添加20 mg/kg硝唑尼特、10 mg/kg阿奇霉素和5 mg/kg利福布汀,持续6周,而第二组在食物中不添加任何治疗。每2个月采集一次肛肠拭子,连续6个月采用探针杂交定量聚合酶链反应(qPCR)检测蛇梭菌的脱落情况。6个月后qPCR阴性的东部靛蓝蛇被单剂量的4mg /kg地塞米松磷酸钠SC免疫抑制。这些东部靛蓝蛇随后被qPCR筛选6个月,如前面所述。连续取样1年后qPCR阴性的东部靛蓝蛇通过胃活检进行组织学和qPCR分析,重新评估蛇舌菌。只有2个(16.7%);95%可信区间[CI]: 0.1 ~ 37.8),各组12条东部靛蓝蛇免疫抑制前qPCR阴性。治疗组东部靛蓝蛇的DNA脱落量确实减少了(P = 0.025),而对照组东部靛蓝蛇的DNA脱落量没有减少(P = 0.232)。只有1人(8.3%);各组12只东部靛蓝蛇免疫抑制6个月后呈阴性(95% CI: 0.1 ~ 23.9)。这些结果表明,在食物中添加20 mg/kg硝唑尼特、10 mg/kg阿奇霉素和5 mg/kg利福布汀,每周2次,连续6周,对自然感染的东部靛蓝蛇的蛇弧菌是无效的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信